Crossmark

Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone

Published Online: 2021-04-21

Published Print: 2021-06

Authors

Standeven, Lindsay R.

Olson, Elizabeth

Leistikow, Nicole

Payne, Jennifer L.

Osborne, Lauren M.

Hantsoo, Liisa
Funding

Funding for this research was provided by:

National Institutes of Health (K23 MH074799)

National Institutes of Health (R01MH112704)

National Institutes of Health (K23 MH110607)

National Institutes of Health (K12HD085845)
License Information

Text and Data Mining valid from 2021-04-21

Version of Record valid from 2021-04-21
More Information

Article History

Accepted: 24 March 2021

First Online: 21 April 2021

Document is current